Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
11/2005
11/09/2005EP1593677A2 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
11/09/2005EP1592687A1 Benzofurane derivatives and the use of the same as antidepressants and anxiolytics
11/09/2005EP1592686A1 Gyrase inhibitors and uses thereof
11/09/2005EP1592685A1 BIPHENYL DERIVATIVES HAVING &bgr; sb 2 /sb ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
11/09/2005EP1592684A1 Malonamide derivatives as gamma-secretase inhibitors
11/09/2005EP1592674A1 Amino 1, 3, 5-triazines n-substituted with chiral bicyclic radicals, process for their preparation, compositions thereof and their use as herbicides and plant growth regulators
11/09/2005EP1592389A2 Piperazine-2-carboxamide derivatives
11/09/2005EP1320611B1 Heterologous production of polyketides
11/09/2005EP1315714B1 Quinazoline derivatives as alpha-1 adrenergic antagonists
11/09/2005EP1254118B1 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005CN1694879A Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
11/09/2005CN1694875A 5-aryltetrazole compounds and uses thereof
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
11/09/2005CN1694708A Inhibitors of tgfbeta
11/09/2005CN1694700A Non-nucleoside reverse transcriptase inhibitors
11/09/2005CN1226292C Diazesuberane derivant or its salt
11/08/2005US6963003 Oxygen-containing heterocyclic fused naphthopyrans
11/08/2005US6962938 Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)
11/08/2005US6962937 Imidazolidine derivatives, their preparation and their use
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962923 Pyrazole compositions
11/08/2005US6962917 E.g., (R)-2-(4-((4-fluoro-1H-benzimidazol-2-ylmethyl)-amino)-piperidin-1-yl)-1-(6- methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria
11/08/2005US6962916 For therapy of retrovirus infection
11/08/2005US6962913 Benzo-1,4-diazepin-2-ones as inhibitors of Aβ protein production
11/08/2005CA2297294C Phosphonomethoxymethylpurine/pyrimidine derivatives
11/08/2005CA2249222C Aminopyridine derivatives
11/08/2005CA2195677C Endothelin antagonists
11/08/2005CA2157288C Methods and compositions for inhibition of angiogenesis
11/08/2005CA2155104C Heterocyclic-substituted alkyl amide acat inhibitors
11/03/2005WO2005103041A2 Treatment of cns disorders using cns target modulators
11/03/2005WO2005103040A1 Cc-1065 analogues for use against cancers
11/03/2005WO2005103039A1 2- (3-aminopyrrolidin-1-yl) pyridines as melanin-concentrating hormone receptor an tagonists
11/03/2005WO2005103038A1 N-[6-(4-morpholinyl)-3-pyridinyl]-2-(tetrahydro-2h-pyran-4-yl)-n-[(1-{[phenyl]methyl}-4-piperidinyl)methyl] acetamide derivatives and related compounds as glyt1 transport inhibitors for the treatment of neurological disorders such as schizophrenia
11/03/2005WO2005103035A1 Modified fischer indole synthesis of eletriptan
11/03/2005WO2005103033A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/03/2005WO2005103031A1 Novel alkyne compounds with an mch-antagonistic action and medicaments containing said compounds
11/03/2005WO2005103030A1 1,4-di substituted benzene compounds, process for preparing the same and use thereof
11/03/2005WO2005103029A1 Novel alkyne compounds having an mch-antagonistic effect and medicaments containing said compounds
11/03/2005WO2005103028A1 2-pyridyl substituted imidazoles as alk5 and/or alk4 inhibitors
11/03/2005WO2005103000A1 N-`4-4(4-morpholinyl) phenyl!-`(4-piperidinyl) methyl! carboxamide derivatives and their use as glycine transporter inhibitors
11/03/2005WO2005102998A1 Novel androgens
11/03/2005WO2005102344A1 Pharmaceutical composition
11/03/2005WO2005102335A2 Methods of treating sleep disorders
11/03/2005WO2005102176A1 Xanthene dyes
11/03/2005WO2005101989A2 Piperidine derivatives as modulators of chemokine receptor ccr5
11/03/2005WO2005054212A3 Electroluminescent device
11/03/2005WO2005003103A3 2, 4, 6-tri-substituted 6-membered heterocycles and their use in the treatment of neurodegenerative diseases
11/03/2005WO2004106304A3 3 - [2- (3-amino-2-oxo-2h-pyridin-1-yl) - acetylamino] - 4- oxo-pentanoic acid derivatives and their use as caspase inhibitors
11/03/2005WO2002004440A9 Composition and antiviral activity of substituted indoleoxoacetic piperazine derivatives
11/03/2005US20050245750 Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative
11/03/2005US20050245747 e.g. 2-[2-(5-chloro-benzo[b]thiophen-2-yl)-phenylmethanesulfinyl]-acetamide; autoimmune disorders, antidepressant; narcolepsy, Parkinson's, Alzheimer's disease; attention deficit hyperactivity disorder; sleep disorder, fatigue
11/03/2005US20050245746 for the solution or solid phase synthesis of carbohydrates; discovering novel drug
11/03/2005US20050245597 Darifenacin solvate with toluene; mixing the free base with toluene to form the solvate, converting to the hydrate, addition salt formation with hydrogen bromide; high purity, extended shelf life; irritable bowel syndrome, incontinence and other gastrointestinal disorders
11/03/2005US20050245596 Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin k inhibitors for the treatment of bone loss
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245586 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12
11/03/2005US20050245581 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents
11/03/2005US20050245572 Naphthyl ether compounds and their use
11/03/2005US20050245555 Tri-substituted ureas as cytokine inhibitors
11/03/2005US20050245551 Amide derivatives
11/03/2005US20050245547 6-((6,7-Bis(methoxy)-4-quinolinyl)oxy)-N-(3-methylphenyl)-1-benzofuran-3-carboxamide;antiproliferative; -metastasis; -carcinogenic; -tumor; -inflammatory; -arthritic agents;hypotensive agents; myocardium necrosis; rheumatic diseases; tyrosine kinase inhibitors; antiallergens; asthma
11/03/2005US20050245527 Nitrogen containing heterocyclic compounds and medicines containing the same
11/03/2005US20050245525 Compounds useful for inhibiting CHK1
11/03/2005US20050245521 3-[-2-(Piperazin-1-yl)benzyl]pyrrolidin-2-one derivatives; antidepressants, anxiolytic agents; obsessive compulsive disorder, psychological disorders, phobias; 5-HT1 agonist or antagonists; side effect reduction, in particular cardiac QTc prolongation; hydrogenation
11/03/2005US20050245520 2-Phenylpyridin-4-yl derivatives as alk5 inhibitors
11/03/2005US20050245511 Novel compounds that inhibit tryptase activity
11/03/2005US20050245503 Therapeutic heterocycles
11/03/2005US20050245501 Succinoylamino lactams as inhibitors of A-beta protein production
11/03/2005US20050245499 Heterocyclic protein kinase inhibitors and uses thereof
11/03/2005US20050245399 Pyrazole derivatives as herbicidal compositions containing them
11/03/2005DE19910403B4 3-Hydroxy-1,2,3,3a-tetrahydro-benzo[b]cyclopent[e]azepin-4,10(5H,10aH)-dion-Derivate enthaltende Arzneimittel 3-hydroxy-1,2,3,3a-tetrahydro-benzo [b] cyclopent [e] azepine-4,10 (5H, 10AH) -dione derivatives of drugs containing
11/03/2005DE102004017935A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
11/03/2005DE102004017933A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
11/03/2005DE102004017932A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
11/03/2005CA2565219A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
11/03/2005CA2563826A1 Treatment of cns disorders using cns target modulators
11/03/2005CA2562571A1 Novel androgens
11/03/2005CA2562417A1 Piperidine derivatives as modulators of chemokine receptor ccr5
11/03/2005CA2562100A1 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
11/03/2005CA2559237A1 Novel alkyne compounds having an mch-antagonistic effect and medicaments containing said compounds
11/03/2005CA2559021A1 Novel alkyne compounds with an mch-antagonistic action and medicaments containing said compounds
11/02/2005EP1591441A1 Carboxylic acid compounds
11/02/2005EP1590358A1 9-ketospinosyn derivatives
11/02/2005EP1590346A1 4- {'3-(sulfonylamino) phenyl! '1-(cyclymethyl) piperidin-4-ylidene! methyl} benazmide derivatives as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder
11/02/2005EP1590345A1 Xanthine derivatives as muscarinic receptor antagonists
11/02/2005EP1590342A1 Diazepanes derivatives useful as lfa inhibitors
11/02/2005EP1590334A1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
11/02/2005EP1590329A1 N-aryl heteroaromatic products, compositions containing same and use thereof
11/02/2005EP1590327A1 Ccr8 inhibitors
11/02/2005EP1590326A2 Substituted alkyl amido piperidines
11/02/2005EP1590325A1 3,6-disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
11/02/2005EP1590319A1 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
11/02/2005EP1476164B1 Quinoxalinones and their use especially in the treatment of cardiovascular diseases
11/02/2005EP1392679B1 Novel 1-amidomethylcarbonyl-piperidine derivatives, method for the production thereof and medicament containing said compounds
11/02/2005EP1377569B1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
11/02/2005EP1283855B1 Stable near-infrared (nir) marker dyes based on benzopyrylium-polymethines
11/02/2005EP1246807B1 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
11/02/2005EP1177190B1 USE OF SELECTIVE ANTAGONISTS OF THE ALPHA 1b-ADRENERGIC RECEPTOR FOR IMPROVEMENT OF SEXUAL DYSFUNCTION
1 ... 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 ... 694